Mark Rutenberg

Mark Rutenberg has devoted the last 20 years to the development, management and marketing of medical diagnostics, with particular concentration in the application of advanced digital image processing techniques to anatomic pathology.

He pioneered the application to the medicine of advanced image processing techniques originally developed for missile defense and is the author of over a dozen patents in the areas of neural networks, image analysis and medical imaging. Mark has founded two companies in this area.

He led his first company, Neuromedical Systems, in what was described by Fortune magazine as "the most successful medical technology IPO of the 1990s." When he left Neuromedical in June of 1997 it was projected to break even within the year with cash reserves in excess of $80M, and its technology for enhancing the accuracy of cervical Pap smears had been adopted by over 250 major US laboratories with another 50 laboratories on a waiting list for training. Mark is a recipient of the Ernst & Young Entrepreneur of the year award in the Life Sciences.